Literature DB >> 24788249

VIP regulates CFTR membrane expression and function in Calu-3 cells by increasing its interaction with NHERF1 and P-ERM in a VPAC1- and PKCε-dependent manner.

Walaa Alshafie1, Frederic G Chappe1, Mansong Li1, Younes Anini2, Valerie M Chappe3.   

Abstract

Vasoactive intestinal peptide (VIP) is a topical airway gland secretagogue regulating fluid secretions, primarily by stimulating cystic fibrosis transmembrane conductance regulator (CFTR)-dependent chloride secretion that contributes to the airways innate defense mechanism. We previously reported that prolonged VIP stimulation of pituitary adenylate cyclase-activating peptide receptors (VPAC1) in airway cells enhances CFTR function by increasing its membrane stability. In the present study, we identified the key effectors in the VIP signaling cascade in the human bronchial serous cell line Calu-3. Using immunocytochemistry and in situ proximity ligation assays, we found that VIP stimulation increased CFTR membrane localization by promoting its colocalization and interaction with the scaffolding protein Na(+)/H(+) exchange factor 1 (NHERF1), a PDZ protein known as a positive regulator for CFTR membrane localization. VIP stimulation also increased phosphorylation, by protein kinase Cε of the actin-binding protein complex ezrin/radixin/moesin (ERM) and its interaction with NHERF1 and CFTR complex. On the other hand, it reduced intracellular CFTR colocalization and interaction with CFTR associated ligand, another PDZ protein known to compete with NHERF1 for CFTR interaction, inducing cytoplasmic retention and lysosomal degradation. Reducing NHERF1 or ERM expression levels by specific siRNAs prevented the VIP effect on CFTR membrane stability. Furthermore, iodide efflux assays confirmed that NHERF1 and P-ERM are necessary for VIP regulation of the stability and sustained activity of membrane CFTR. This study shows the cellular mechanism by which prolonged VIP stimulation of airway epithelial cells regulates CFTR-dependent secretions.
Copyright © 2014 the American Physiological Society.

Entities:  

Keywords:  Na+/H+ exchange factor 1; cystic fibrosis associated ligand; cystic fibrosis transmembrane conductance regulator; ezrin/radixin/moesin; protein kinase C epsilon; vasoactive intestinal peptide

Mesh:

Substances:

Year:  2014        PMID: 24788249     DOI: 10.1152/ajpcell.00296.2013

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  13 in total

1.  Regulation of the cystic fibrosis transmembrane conductance regulator anion channel by tyrosine phosphorylation.

Authors:  Arnaud Billet; Yanlin Jia; Tim Jensen; John R Riordan; John W Hanrahan
Journal:  FASEB J       Date:  2015-06-10       Impact factor: 5.191

Review 2.  Current insights into the role of PKA phosphorylation in CFTR channel activity and the pharmacological rescue of cystic fibrosis disease-causing mutants.

Authors:  Stephanie Chin; Maurita Hung; Christine E Bear
Journal:  Cell Mol Life Sci       Date:  2016-10-08       Impact factor: 9.261

3.  Distribution of PACAP and PAC1 Receptor in the Human Eye.

Authors:  Evelin Patko; Edina Szabo; Denes Toth; Tamas Tornoczky; Inez Bosnyak; Alexandra Vaczy; Tamas Atlasz; Dora Reglodi
Journal:  J Mol Neurosci       Date:  2022-03-07       Impact factor: 3.444

Review 4.  One Size Does Not Fit All: The Past, Present and Future of Cystic Fibrosis Causal Therapies.

Authors:  Marjolein M Ensinck; Marianne S Carlon
Journal:  Cells       Date:  2022-06-08       Impact factor: 7.666

Review 5.  From the endoplasmic reticulum to the plasma membrane: mechanisms of CFTR folding and trafficking.

Authors:  Carlos M Farinha; Sara Canato
Journal:  Cell Mol Life Sci       Date:  2016-10-03       Impact factor: 9.261

6.  The FOXP2-Driven Network in Developmental Disorders and Neurodegeneration.

Authors:  Franz Oswald; Patricia Klöble; André Ruland; David Rosenkranz; Bastian Hinz; Falk Butter; Sanja Ramljak; Ulrich Zechner; Holger Herlyn
Journal:  Front Cell Neurosci       Date:  2017-07-26       Impact factor: 5.505

7.  Vasoactive Intestinal Peptide Derived From Liver Mesenchymal Cells Mediates Tight Junction Assembly in Mouse Intrahepatic Bile Ducts.

Authors:  Ayako Sato; Sei Kakinuma; Masato Miyoshi; Akihide Kamiya; Tomoyuki Tsunoda; Shun Kaneko; Jun Tsuchiya; Taro Shimizu; Eiko Takeichi; Sayuri Nitta; Fukiko Kawai-Kitahata; Miyako Murakawa; Yasuhiro Itsui; Mina Nakagawa; Seishin Azuma; Naohiko Koshikawa; Motoharu Seiki; Hiromitsu Nakauchi; Yasuhiro Asahina; Mamoru Watanabe
Journal:  Hepatol Commun       Date:  2019-12-24

Review 8.  New Therapies to Correct the Cystic Fibrosis Basic Defect.

Authors:  Christelle Bergeron; André M Cantin
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923

Review 9.  CFTR Modulators: Shedding Light on Precision Medicine for Cystic Fibrosis.

Authors:  Miquéias Lopes-Pacheco
Journal:  Front Pharmacol       Date:  2016-09-05       Impact factor: 5.810

Review 10.  CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine.

Authors:  Miquéias Lopes-Pacheco
Journal:  Front Pharmacol       Date:  2020-02-21       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.